Insider · CIK 0001438327
Warren Hosseinion
Files at NUTX (Nutex Health Inc.), VRXA (Veraxa Biotech AG). First filing Mar 23, 2026, latest Sep 29, 2026.
In brief
Warren Hosseinion files SEC Form 4 as director and president at NUTX (Nutex Health Inc.), and also at VRXA (Veraxa Biotech AG). Since Mar 23, 2026, Warren Hosseinion has reported 2 open-market buys worth $34k and 0 open-market sells worth $0, the latest filed on Sep 29, 2026.
A track record needs three past buys with six months of prices behind them; Warren Hosseinion has 0, so none is measured yet.
The newest scored trade: bought $10k of VRXA on Sep 10, 2026, filed Sep 29, 2026, scored 10 (weak). In the last 12 months: 2 buys worth $34k and 0 sells worth $0.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
VRXA: Veraxa Biotech AG
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
NUTX: Nutex Health Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | VRXAbuy Veraxa Biotech AG | $10k 6,024 shares | +1% | - | |
| 43Moderate | Nutex Health Inc. | $24k 252 shares | +3% | +101% from low-50% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | VRXA Veraxa Biotech AG | POpen-market purchase Ordinary Shares | +6,024 | $1.67 | $10k | 634,692 | 14 d ago |
| Mar 19, 2026 | NUTX Nutex Health Inc. | POpen-market purchase Common Stock | +252 | $94.07 | $24k | 7,765 | Mar 23, 2026 |
| Mar 10, 2026 | NUTX Nutex Health Inc. | MOption exercise Restricted Stock Unitsderivative | +3,656 | $0.00 | $0 | 12,465 | Mar 23, 2026 |
| Mar 10, 2026 | NUTX Nutex Health Inc. | MOption exercise Common Stock | +6,293 | $0.00 | $0 | 10,787 | Mar 11, 2026 |
| Mar 10, 2026 | NUTX Nutex Health Inc. | FTax withholding Common Stock | -3,274 | $86.22 | $282k | 7,513 | Mar 11, 2026 |
| Mar 10, 2026 | NUTX Nutex Health Inc. | MOption exercise Restricted Stock Unitsderivative | +3,656 | $0.00 | $0 | 15,739 | Mar 11, 2026 |
| Mar 1, 2025 | NUTX Nutex Health Inc. | MOption exercise Common Stock | +3,776 | $0.00 | $0 | 4,494 | Apr 14, 2025 |
| Apr 4, 2025 | NUTX Nutex Health Inc. | FTax withholding Common Stock | -1,072 | $72.10 | $77k | 3,422 | Apr 14, 2025 |
| Mar 10, 2025 | NUTX Nutex Health Inc. | MOption exercise Restricted Stock Unitsderivative | +7,551 | $0.00 | $0 | 15,102 | Apr 14, 2025 |
Questions about Warren Hosseinion
Answered from the filings on this page, as of the latest one.
Is Warren Hosseinion buying or selling?
In the last 12 months Warren Hosseinion reported 2 open-market buys worth $34k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $10k of VRXA on Sep 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Warren Hosseinion's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Warren Hosseinion has 0.
Where does Warren Hosseinion file Form 4?
Warren Hosseinion has filed Form 4 at NUTX (Nutex Health Inc.) as President; VRXA (Veraxa Biotech AG). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.